Grace Therapeutics, Inc. — Form D

Grace Therapeutics, Inc. of Princeton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-25. The offering totals $30.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
A. Brian DavisDirectorWinston-Salem, NC
Vimal KavuruDirectorPrinceton, NJ
Prashant KohliDirectorPrinceton, NJ
S. George KottayilDirectorPrinceton, NJ
Edward NeugeborenDirectorPrinceton, NJ
Carrie D'AndreaExecutive OfficerPrinceton, NJ
Robert J. DelAversanoExecutive OfficerPrinceton, NJ
Prashant KohliExecutive OfficerPrinceton, NJ
Amresh KumarExecutive OfficerPrinceton, NJ
Dr. R. Loch MacdonaldExecutive OfficerPrinceton, NJ
Donald OldsDirectorMcLean, VA
Brian FordExecutive OfficerCharlotte, NC
Michael DerbyDirectorLaval, A8
Ronald DenisDirectorLaval, A8
Jean-Marie (John) N CananDirectorLaval, A8
Linda P O'KeefeExecutive OfficerLaval, A8
Donald N OldsDirectorLaval, A8
Roderick N CarterDirectorLaval, A8
Janelle D'AlviseDirectorLaval, A8
Janelle D'AlviseExecutive OfficerLaval, A8
Marc LebelDirectorChelmsford, MA
MARTIN GODBOUTDirectorMONTREAL, A8
Tina SampalisExecutive OfficerLAVAL, A8
Michel ChartrandDirectorLAVAL, A8
Henri HarlandDirectorLAVAL, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2023-10-10D$15.1M$7.5M
2018-05-25D$838K$373K
2011-09-02D$170K

More